Summary
- Current Price
- As of today, NRIX price is $24.26, up +1.72% on
- Current Price All-Time High
- NRIX price is currently -53.68% below its historical high of $52.38 set on
- Market Cap
- NRIX current market cap is $3B, up +188.16% over the past 365 days
- PE Ratio
- NRIX PE ratio is unknown
- Revenue
- NRIX current annual revenue is $83.98M, up +53.95% year-over-year
- Next Earnings
- The next earnings release for NRIX is on
Profile
| Metric | Value |
|---|---|
| Full Name | Nurix Therapeutics, Inc. |
| Ticker | NASDAQ: NRIX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | nurixtx.com |
| Employees | 286 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $24.26 | |
| Price, 1D Change | +1.72% | |
| $3B | ||
| - | ||
| - | ||
| 1.59 | ||
| $84M | ||
| Revenue, 1Y Change | +53.95% | |
| -$3.05 | ||
| EPS, 1Y Change | -5.81% |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$3.05 | ||
| EPS Estimate | N/A | -$2.35 |
| EPS Est. Change | N/A | +22.87% |
| $83.98M | ||
| Revenue Estimate | N/A | $142.44M |
| Revenue Est. Change | N/A | +69.62% |
| Current Price | $24.26 | |
| Price Target | - | $32.00 |
| Price Tgt. Change | - | +31.90% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$2.77 | -$2.88 | -4.13% | |
| -$3.10 | -$3.05 | +1.55% | |
| -$2.35 | N/A | +22.87% | |
| -$2.67 | N/A | +12.47% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $54.66M | $54.55M | -0.20% | |
| $85.23M | $83.98M | -1.46% | |
| $142.44M | N/A | +69.62% | |
| $81.63M | N/A | -2.80% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Date | Value |
|---|---|---|
| Current Price | $24.26 | |
| $15.50 | ||
| $17.23 | ||
| $16.00 | ||
| $17.72 | ||
| $1.74 | ||
| 1.59 | ||
| $1.37 | ||
| 84.77 | ||
| 76.35% | ||
| 63.77% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $83.98M | ||
| -$3.05 | ||
| $65.12M | ||
| 77.55% | ||
| -$285.67M | ||
| -340.16% | ||
| -$264.46M | ||
| -314.90% | ||
| -$266.81M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.10 | ||
| 7.02 | ||
| 7.02 | ||
| - | ||
| 2 | ||
| 6.86 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 34.95 | ||
| 5.22 | ||
| -6.83 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $538.75M | ||
| $592.94M | ||
| $702.56M | ||
| $606.82M | ||
| $163.82M | ||
| $86.47M | ||
| $55.73M | ||
| $2.82M | ||
| $11.22M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $348.44M | ||
| $350.79M | ||
| $18.86M | ||
| $0.00 | ||
| $18.86M | ||
| $0.00 | ||
| $760.00K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$249.47M | ||
| $147.85M | ||
| $238.64M | ||
| $14.00M | ||
| -$263.47M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Baird | → | |
| Needham | → | |
| HC Wainwright & Co. | → | |
| Truist Securities | → | |
| BTIG | → | |
| Wells Fargo | → | |
| Needham | → | |
| Jefferies | → | |
| BTIG | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with NRIX
FAQ
What is the ticker symbol for Nurix Therapeutics, Inc.?
The ticker symbol for Nurix Therapeutics, Inc. is NASDAQ:NRIX
Does Nurix Therapeutics, Inc. pay dividends?
No, Nurix Therapeutics, Inc. does not pay dividends
What sector is Nurix Therapeutics, Inc. in?
Nurix Therapeutics, Inc. is in the Healthcare sector
What industry is Nurix Therapeutics, Inc. in?
Nurix Therapeutics, Inc. is in the Biotechnology industry
What country is Nurix Therapeutics, Inc. based in?
Nurix Therapeutics, Inc. is headquartered in United States
When did Nurix Therapeutics, Inc. go public?
Nurix Therapeutics, Inc. initial public offering (IPO) was on July 24, 2020
Is Nurix Therapeutics, Inc. in the S&P 500?
No, Nurix Therapeutics, Inc. is not included in the S&P 500 index
Is Nurix Therapeutics, Inc. in the NASDAQ 100?
No, Nurix Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Nurix Therapeutics, Inc. in the Dow Jones?
No, Nurix Therapeutics, Inc. is not included in the Dow Jones index
When was Nurix Therapeutics, Inc. last earnings report?
Nurix Therapeutics, Inc.'s most recent earnings report was on April 8, 2026
When does Nurix Therapeutics, Inc. report earnings?
The next expected earnings date for Nurix Therapeutics, Inc. is July 9, 2026
Data Sources & References
- NRIX Official Website www.nurixtx.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1549595/000154959526000016/0001549595-26-000016-index.htm
- NRIX Profile on Yahoo Finance finance.yahoo.com/quote/NRIX
- NRIX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/nrix